サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1386330

臨床試験イメージング市場レポート：2030年までの動向、予測、競合分析

Clinical Trial Imaging Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

臨床試験イメージング市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

臨床試験イメージングの動向と予測

世界の臨床試験イメージング市場は、2024年から2030年までのCAGRが7.6%で、2030年までに推定21億米ドルに達すると予想されます。この市場の主な促進要因は、CROの増加、製薬業界とバイオテクノロジー業界の著しい成長、医薬品や治療法を発見するための研究開発費の増加です。世界の臨床試験イメージング市場は、製薬会社、バイオテクノロジー企業、医療機器メーカー、開発業務受託機関、学術研究機関、政府研究機関の各市場におけるビジネスチャンスにより、将来が有望視されています。

臨床試験イメージング市場の洞察

Lucintelの予測では、受託研究機関（CRO）の存在感の高まりや研究開発投資の増加などにより、予測期間中はコンピュータ断層撮影が最大セグメントであり続ける。

同市場では、慢性疾患への対処を目的とした新たな治療法や薬剤の需要が増加していることから、製薬会社が引き続き最大セグメントとなります。

北米は、大手アウトソーシング企業の存在と同地域における研究開発の増加により、予測期間中に最も高い成長が見込まれています。慢性疾患の増加とともに、高齢者人口の増加などの様々な要因が北米市場を牽引すると予測されています。

本レポートは以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の臨床試験イメージング市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の臨床試験イメージング市場の動向（2018～2023年）と予測（2024～2030年）
  • 製品およびサービス別の世界の臨床試験イメージング市場
    • ソフトウェア
    • サービス
  • モダリティ別の世界の臨床試験イメージング市場
    • コンピュータ断層撮影
    • 磁気共鳴画像
    • 超音波
    • 陽電子放出断層撮影
    • X線
    • 心エコー検査
  • 治療領域別の世界の臨床試験イメージング市場
    • オンコロジー
    • 感染症
    • 神経内科
    • CVS
    • 内分泌学
    • 免疫疾患
  • 最終用途別の世界の臨床試験イメージング市場
    • 製薬会社
    • バイオテクノロジー企業
    • 医療機器メーカー
    • 受託調査機関
    • 学術および政府の調査機関
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の臨床試験イメージング市場
  • 北米の臨床試験イメージング市場
  • 欧州臨床試験イメージング市場
  • アジア太平洋臨床試験イメージング市場
  • その他地域臨床試験イメージング市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品およびサービス別の世界の臨床試験イメージング市場の成長機会
    • モダリティ別の世界の臨床試験イメージング市場の成長機会
    • 治療領域別の世界の臨床試験イメージング市場の成長機会
    • 最終用途別の世界の臨床試験イメージング市場の成長機会
    • 地域別の世界の臨床試験イメージング市場の成長機会
  • 世界の臨床試験イメージング市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の臨床試験イメージング市場の能力拡大
    • 世界の臨床試験イメージング市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • ICON
  • Biotelemetry
  • Medpace Holdings
  • Biomedical Systems Corporation
  • Bioclinica
  • IXICO
  • Resonance Health
  • Radiant Sage
  • Intrinsic Imaging
  • Cardiovascular Imaging Technologies
目次

Clinical Trial Imaging Trends and Forecast

The future of the global clinical trial imaging market looks promising with opportunities in the pharmaceutical company, biotechnology company, medical device manufacturer, contract research organization, academic and government research institute markets. The global clinical trial imaging market is expected to reach an estimated $2.1 billion by 2030 with a CAGR of 7.6% from 2024 to 2030. The major drivers for this market are increasing number of CROs, significantly growing pharmaceutical and biotechnology industries, and increasing R&D spending to discover drugs and therapies.

A more than 150-page report is developed to help in your business decisions.

Clinical Trial Imaging by Segment

The study includes a forecast for the global clinical trial imaging by product & services, modality, therapeutic area, end use, and region.

Clinical Trial Imaging Market by Product & Services [Shipment Analysis by Value from 2018 to 2030]:

  • Software
  • Services

Clinical Trial Imaging Market by Modality [Shipment Analysis by Value from 2018 to 2030]:

  • Computed Tomography
  • Magnetic Resonance Imaging
  • Ultrasound
  • Positron Emission Tomography
  • X-ray
  • Echocardiography

Clinical Trial Imaging Market by Therapeutic Area [Shipment Analysis by Value from 2018 to 2030]:

  • Oncology
  • Infectious Diseases
  • Neurology
  • CVS
  • Endocrinology
  • Immunological Disorder

Clinical Trial Imaging Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Manufacturer
  • Contract Research Organizations
  • Academic and Government Research Institutes
  • Others

Clinical Trial Imaging Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Clinical Trial Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies clinical trial imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the clinical trial imaging companies profiled in this report include-

  • Icon
  • Biotelemetry
  • Medpace Holdings
  • Biomedical Systems Corporation
  • Bioclinica
  • Ixico
  • Resonance Health
  • Radiant Sage
  • Intrinsic Imaging
  • Cardiovascular Imaging Technologies

Clinical Trial Imaging Market Insights

Lucintel forecasts that computed tomography will remain the largest segment over the forecast period due to including the increasing presence of contract research organizations (CROs) and rising research and development investments.

Within this market, pharmaceutical companies will remain the largest segment due to increasing demand for new treatments and medications aimed at addressing chronic diseases.

North America is expected to witness highest growth over the forecast period due to the presence of big outsourcing companies and an increase in r&d in the region. various factors such as the increasing geriatric population along with growing chronic diseases are projected to drive the market in north america. north america also performs the maximum number of clinical trials.

Features of the Global Clinical Trial Imaging Market

Market Size Estimates: Clinical trial imaging market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Clinical trial imaging market by various segments, such as by product & services, modality, therapeutic area, end use and region in terms of($B).

Regional Analysis: Clinical trial imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product & services, modalities, therapeutic areas, end uses, and regions for the clinical trial imaging market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the clinical trial imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the clinical trial imaging market size?

Answer: The global clinical trial imaging market is expected to reach an estimated $2.1 billion by 2030.

Q.2 What is the growth forecast for clinical trial imaging market?

Answer: The global clinical trial imaging market is expected to grow with a CAGR of 7.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the clinical trial imaging market?

Answer: The major drivers for this market are increasing number of CROs, significantly growing pharmaceutical and biotechnology industries, and increasing R&D spending to discover drugs and therapies.

Q4. What are the major segments for clinical trial imaging market?

Answer: The future of the clinical trial imaging market looks promising with opportunities in the pharmaceutical company, biotechnology company, medical device manufacturer, contract research organization, academic and government research institute markets.

Q5. Who are the key clinical trial imaging market companies?

Answer: Some of the key clinical trial imaging companies are as follows:

  • ICON
  • Biotelemetry
  • Medpace Holdings
  • Biomedical Systems Corporation
  • Bioclinica
  • IXICO
  • Resonance Health
  • Radiant Sage
  • Intrinsic Imaging
  • Cardiovascular Imaging Technologies

Q6. Which clinical trial imaging market segment will be the largest in future?

Answer: Lucintel forecasts that computed tomography will remain the largest segment over the forecast period due to including the increasing presence of contract research organizations (CROs) and rising research and development investments.

Q7. In clinical trial imaging market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the presence of big outsourcing companies and an increase in r&d in the region. various factors such as the increasing geriatric population along with growing chronic diseases are projected to drive the market in north america. north america also performs the maximum number of clinical trials.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the clinical trial imaging market by product & services (software and services), modality (computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, X-ray, and echocardiography), therapeutic area (oncology, infectious diseases, neurology, CVS, endocrinology, and immunological disorder), end use (pharmaceutical companies, biotechnology companies, medical device manufacturer, contract research organizations, academic and government research institutes, and others),and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Clinical Trial Imaging Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Clinical Trial Imaging Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Clinical Trial Imaging Market by Product & Services
    • 3.3.1: Software
    • 3.3.2: Services
  • 3.4: Global Clinical Trial Imaging Market by Modality
    • 3.4.1: Computed Tomography
    • 3.4.2: Magnetic Resonance Imaging
    • 3.4.3: Ultrasound
    • 3.4.4: Positron Emission Tomography
    • 3.4.5: X-ray
    • 3.4.6: Echocardiography
  • 3.5: Global Clinical Trial Imaging Market by Therapeutic Area
    • 3.5.1: Oncology
    • 3.5.2: Infectious Diseases
    • 3.5.3: Neurology
    • 3.5.4: CVS
    • 3.5.5: Endocrinology
    • 3.5.6: Immunological Disorder
  • 3.6: Global Clinical Trial Imaging Market by End Use
    • 3.6.1: Pharmaceutical Companies
    • 3.6.2: Biotechnology Companies
    • 3.6.3: Medical Device Manufacturer
    • 3.6.4: Contract Research Organizations
    • 3.6.5: Academic and Government Research Institutes
    • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Clinical Trial Imaging Market by Region
  • 4.2: North American Clinical Trial Imaging Market
    • 4.2.2: North American Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others
  • 4.3: European Clinical Trial Imaging Market
    • 4.3.1: European Clinical Trial Imaging Market by Modality: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-ray, and Echocardiography
    • 4.3.2: European Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others
  • 4.4: APAC Clinical Trial Imaging Market
    • 4.4.1: APAC Clinical Trial Imaging Market by Modality: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-ray, and Echocardiography
    • 4.4.2: APAC Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others
  • 4.5: ROW Clinical Trial Imaging Market
    • 4.5.1: ROW Clinical Trial Imaging Market by Modality: Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-ray, and Echocardiography
    • 4.5.2: ROW Clinical Trial Imaging Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Academic & Government Research Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Clinical Trial Imaging Market by Product & Services
    • 6.1.2: Growth Opportunities for the Global Clinical Trial Imaging Market by Modality
    • 6.1.3: Growth Opportunities for the Global Clinical Trial Imaging Market by Therapeutic Area
    • 6.1.4: Growth Opportunities for the Global Clinical Trial Imaging Market by End Use
    • 6.1.5: Growth Opportunities for the Global Clinical Trial Imaging Market by Region
  • 6.2: Emerging Trends in the Global Clinical Trial Imaging Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Clinical Trial Imaging Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Clinical Trial Imaging Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: ICON
  • 7.2: Biotelemetry
  • 7.3: Medpace Holdings
  • 7.4: Biomedical Systems Corporation
  • 7.5: Bioclinica
  • 7.6: IXICO
  • 7.7: Resonance Health
  • 7.8: Radiant Sage
  • 7.9: Intrinsic Imaging
  • 7.10: Cardiovascular Imaging Technologies